Scientists who have devoted years developing medicines to cure disease are now working for tobacco companies to make e-cigarettes. Philip Morris International Inc (PMI) has hired more than 400 scientists and technical staff at its research facility in Neuchatel, Switzerland, including toxicologists, chemists, biologists, biostatisticians and regulatory affairs experts.
Altria Group Inc, makers of Marlboro, has recruited dozens of scientific and healthcare experts, as have independent e-cigarette companies such as NJOY. They bring experience developing inhalation devices and navigating the U.S. Food and Drug Administration (FDA), valuable knowledge in the new world of electronic cigarettes. They say they’re trying to improve public health.
“We were looking at drugs that make people very ill and maybe extend their life by 12-14 weeks” said Gizelle Baker a PMI biostatistician based in Neuchatel. She previously worked at the cancer drug developer Poniard Pharmaceuticals. “If you have a product that prevents cancer in the first place you can have a much bigger impact on public health.” The goal is to improve the current generation of e-cigarettes and, where possible, provide evidence that they reduce the risk of disease. Companies that succeed could have an advantage in a market that Bonnie Herzog, an analyst at Wells Fargo Securities, sees surpassing combustible cigarettes in the U.S. within 10 years. Read full article
Toni Clarke (23 June 2015) Scientists join tobacco companies to fight cancer [news]. Retrieved from http://tinyurl.com/ogkvhhy